Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models.
about
Immunotherapeutic approaches for Alzheimer's diseaseAmyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.Novel immunological approaches for the treatment of Alzheimer's disease.Chemical Fluorescent Probe for Detection of Aβ Oligomers.Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.Developing therapeutic vaccines against Alzheimer's disease.MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.Alzheimer's disease and immunotherapy: what is wrong with clinical trials?Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline.Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease.Combination of Aβ Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition.Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
P2860
Q28081278-8F26A758-3482-4A21-8D63-B43E7C4BE565Q34227162-5DBDB149-52A4-47E5-995D-C24CD1103088Q34562675-D69B1D7B-FBEB-410E-ACCF-2861CCC232EAQ35719664-C12DFA58-F098-49FB-9E01-2A27BE90B2F8Q35907101-3CB211EE-8AC8-459B-8620-393488471E6DQ36469146-F78B775B-217D-471C-AB7E-8C407420762CQ37630548-887D2D7E-A1FC-4A1D-B176-5E59A80C6840Q38204620-5105BAB2-ED9C-4438-BF07-B4017527F700Q38636151-79173747-FF00-47AB-B2DB-241D7D9FF75EQ38892738-B94CF324-D167-4F40-AF08-1F89EEAC36DDQ38912275-5A7810BA-B2D4-432C-9BA7-FB75ACA57FDFQ41387476-65ED1A1E-A565-43D5-97ED-270648C5A871Q41548991-7C457FB8-A720-48B8-80B1-92A4D9B30046Q41582362-A8DCA7DE-82F3-47CB-8265-626F9BC8E81CQ41935920-61903608-B028-43C9-94A4-90BB313C450BQ47833979-A4612F69-9A9C-45A1-86F4-CC6338FDA92CQ55365163-33EBEFD7-6BAF-46AE-B81A-8C9AA7F74508
P2860
Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunomodulation targeting of ...... TgSwDI and 3xTg mouse models.
@en
type
label
Immunomodulation targeting of ...... TgSwDI and 3xTg mouse models.
@en
prefLabel
Immunomodulation targeting of ...... TgSwDI and 3xTg mouse models.
@en
P2093
P2860
P356
P1476
Immunomodulation targeting of ...... TgSwDI and 3xTg mouse models.
@en
P2093
Daniel Peyser
Fernando Goñi
Kinlung Wong
Krystal Herline
Pankaj Mehta
Yanjie Sun
P2860
P2888
P356
10.1186/1742-2094-10-150
P577
2013-12-13T00:00:00Z
P5875
P6179
1018930686